Santersus
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 2
About Santersus
Santersus AG, founded in 2017, operates from Zurich, Switzerland, focusing on therapeutic apheresis.Santersus specializes in innovative therapeutic apheresis solutions, with a primary focus on the NucleoCapture selective apheresis device. This first-in-class product is designed to remove neutrophil extracellular traps (NETs) from patient blood, addressing critical health challenges associated with conditions such as sepsis, COVID-19, cancer, acute organ failure, autoimmune diseases like lupus, and neurodegenerative disorders including Alzheimer’s disease. The device functions by selectively capturing and extracting these harmful cellular structures, thereby mitigating their detrimental effects on the immune system and inflammatory response. Santersus targets hospitals, clinics, and healthcare providers across Europe and North America, providing treatment options to patients suffering from severe inflammatory and immune-mediated conditions.The business model of Santersus revolves around the sale of its NucleoCapture device to healthcare institutions, establishing direct B2B transactions with hospitals and clinics. Revenue generation is primarily driven through the initial purchase of the device, along with potential ongoing maintenance and support agreements. These agreements may include service packages that ensure optimal device functionality and training for medical staff. Revenue is further augmented by partnerships with healthcare providers that may involve collaborative research and development efforts aimed at improving the efficacy of the device in various clinical settings.
Who invested in Santersus
2 investors across 1 round
See all investors in Santersus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 1, 2025
Amount
Undisclosed
Investors
Questions about Santersus
Who invested in Santersus?
Santersus has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Santersus raised?
Santersus has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Santersus last raise money?
Santersus's most recent round on record is a Series A, in Dec 2025.
What does Santersus do?
Santersus AG, founded in 2017, operates from Zurich, Switzerland, focusing on therapeutic apheresis.
Where is Santersus headquartered?
Santersus is headquartered in Zurich, Switzerland.
Which VCs invest in companies like Santersus?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Santersus's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Santersus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.